Tag: Healthcare

  • Big Data Insights: Key Trends, Tools, and Industry Impact in 2025-2026

    Analytics Insight’s Big Data section curates essential articles exploring the transformative power of data analytics across industries. From open-source tools to predictive market analysis, these pieces uncover how organizations leverage big data for strategic advantage.

    Top Headlines

    • Best Open-Source Big Data Tools in 2026: A comprehensive guide to the most effective open-source platforms for handling massive datasets.
    • What is Big Data Analytics? (2026 Guide): Explains the meaning, types, tools, and real-world applications of big data analytics.
    • The Growing Role of Big Data in Predictive Market Analysis: How data-driven models forecast market trends with increasing accuracy.
    • Big Data in Telehealth and Remote Diagnostics: Transforming patient care through real-time data processing and remote monitoring.
    • Gartner’s Essential Features for BI Platforms (2025): Key capabilities business intelligence tools must offer in the modern data landscape.
    • Top Free Scala Courses for Big Data (2025): Learning resources for mastering Scala, a language critical for big data frameworks.
    • Drinksworld Uses Big Data for Business Growth: A case study on how data analytics drives strategy in the beverage industry.
    • Big Data Reshaping the Automotive Industry: From autonomous driving to supply chain optimization, data is revolutionizing mobility.
    • Big Data Revolution in Healthcare: Predictive analytics and precision medicine are becoming standard through big data.
    • Top 10 Data Lakes for Big Data Analytics: A detailed overview of leading data lake solutions for scalable analytics.
    • Big Data Analytics Trends to Watch in 2025: Emerging patterns that will define the next wave of data analytics.
    • Why the World Would End Without Data: A thought piece on the catastrophic consequences of a data-less society.

    These articles provide a rich resource for professionals, researchers, and enthusiasts looking to stay ahead in the rapidly evolving world of big data.

  • Big Data Insights: Top Tools, Analytics Trends, and Industry Impact for 2025-2026

    What Is Big Data Analytics?

    Big Data analytics involves examining large, diverse data sets to uncover hidden patterns, correlations, and insights. In 2025-2026, open-source tools, predictive analytics, and industry-specific applications are driving transformation across healthcare, automotive, finance, and more.

    Top Trends and Tools

    • Best Open-Source Big Data Tools in 2026 – A roundup of leading open-source platforms for data processing and analysis.
    • Predictive Market Analysis – How Big Data is reshaping market forecasting and investment strategies.
    • Telehealth and Remote Diagnostics – Big Data’s role in improving patient monitoring and diagnostic accuracy.
    • Business Intelligence Platforms – Gartner’s essential features for BI tools in 2025.
    • Scala for Big Data – Top free courses to master Scala for data engineering.
    • Data Lakes for Analytics – The top 10 data lakes enabling large-scale analytics.

    Industry Applications

    Big Data is revolutionizing the automotive industry, healthcare (predictive analytics and precision medicine), and even the beverage sector (drinksworld uses data to drive growth). Without Big Data, modern decision-making would collapse—highlighting its critical role.

    Stay tuned for more insights from Analytics Insight, the leading tech and crypto publication.

  • Accenture Acquires Alfahealth to Advance AI-Powered Healthcare in Italy

    Accenture Acquires Alfahealth to Advance AI-Powered Healthcare in Italy

    Accenture has announced its agreement to acquire Alfahealth, an Italian digital health technology company, in a move that underscores the growing importance of artificial intelligence in healthcare. The acquisition aims to strengthen Accenture’s capabilities in delivering AI-driven, data-secure, and personalized care across Italy’s healthcare system.

    Alfahealth brings over two decades of experience in developing digital health platforms that support patient journeys, clinical workflows, diagnostics, and administrative operations. By integrating Alfahealth’s technology with Accenture’s expertise in AI, cloud computing, cybersecurity, and data analytics, healthcare organizations will gain access to more intelligent and connected systems. These systems can unify data from hospitals, clinics, community providers, and public institutions, enabling advanced AI applications such as predictive analytics, automated workflow optimization, and real-time clinical insights.

    Teodoro Lio, Market Unit Lead for Accenture in Italy, emphasized the strategic timing: “Italy is at a pivotal moment in the transformation of its healthcare system, with growing investments in digital health, interoperability, and new models of care.” He added that the combination will help healthcare providers accelerate innovation, improve care delivery, and enable more connected, data-driven experiences for all Italians.

    The acquisition also adds approximately 1,200 healthcare specialists to Accenture’s team, bolstering its ability to deliver large-scale transformation initiatives. As healthcare systems face pressure from aging populations and rising demand, AI-driven automation and decision support are becoming essential. This deal positions Accenture to help Italy move toward predictive, preventive, and personalized care models, leveraging AI for earlier disease detection, optimized resource allocation, and enhanced patient engagement.

  • Mount Sinai Uses AI to Detect Pregnancy Risks Earlier, From Preconception to Ultrasound

    Mount Sinai Uses AI to Detect Pregnancy Risks Earlier, From Preconception to Ultrasound

    Mount Sinai, a leading US teaching hospital, is pioneering artificial intelligence tools to identify pregnancy risks much earlier in the care pathway. The work targets two critical stages: before conception for placenta accreta spectrum (PAS) and during routine mid-trimester scans for congenital heart defects (CHD). Both conditions carry high morbidity and require intensive resources.

    At the 2026 SMFM Annual Pregnancy Meeting, Mount Sinai specialists presented an AI-assisted workflow for detecting severe CHD from fetal ultrasound and machine learning models that predict PAS risk using preconception electronic medical record (EMR) data. The research also incorporates social vulnerability, gun violence exposure, and labor management signals, pointing toward a more comprehensive, data-informed approach to pregnancy care.

    In a case-control study of 118,890 deliveries from 2013 to 2023, PAS occurred in 0.23% of cases but posed severe maternal morbidity and mortality risks. The AI identified anemia before pregnancy as a previously unrecognized risk factor. Because anemia is potentially modifiable, health systems could intervene through nutritional support, consults, or preconception counseling, aiming to reduce emergency deliveries and enable planned care at specialized hospitals.

    The team trained multiple machine learning models on pre-pregnancy EMR data. An XGBoost model achieved an area under the ROC curve of 0.86, outperforming logistic regression at 0.76. Random forest provided the highest sensitivity at 91%, while logistic regression achieved 91% specificity, highlighting trade-offs between catching more cases and triggering fewer false alarms.

    On the imaging side, Mount Sinai West deployed BrightHeart software to enhance fetal ultrasound screening for major CHD. In a study of 200 second-trimester ultrasounds from 11 medical centers across two countries, AI assistance raised detection of major CHD to over 97%, cut reading time by 18%, and increased reader confidence by 19%. The technology is now being evaluated in a real-world prenatal diagnostic center, flagging suspicious findings within standard screening workflows.

    Mount Sinai emphasizes rigorous validation on diverse populations, careful stewardship of large datasets, and continuous monitoring for bias. The institution calls for clear clinical sponsorship with metrics tied to morbidity, cost, and workflow, along with a deliberate plan to scale from single-center pilots to system-wide decision support. By pairing EMR-driven preconception risk prediction for PAS with AI-augmented fetal cardiac imaging, Mount Sinai is redefining when and how pregnancy risk is identified, offering tangible gains in accuracy, efficiency, and care planning.

  • Pangaea Data and Sanofi Use AI to Detect Rare Disease Alpha-1 Antitrypsin Deficiency

    Pangaea Data and Sanofi Use AI to Detect Rare Disease Alpha-1 Antitrypsin Deficiency

    Pangaea Data, a provider of guideline-configured AI solutions, has partnered with Sanofi to deploy machine learning algorithms that analyze electronic health record (EHR) data. The collaboration aims to identify patients with Alpha-1 Antitrypsin Deficiency (AATD) earlier, addressing the chronic underdiagnosis of this rare genetic disorder across the United States.

    Research indicates that up to 90% of individuals with AATD remain undiagnosed, often waiting five to eight years for confirmation after symptoms appear. The AI platform processes real-time clinical data, including structured fields and unstructured physician notes, to flag patients who may need further evaluation without adding administrative burden.

    “We are pleased to support the deployment of innovative solutions like Pangaea’s platform that can help not only identify patients in need of evaluation earlier using real-time, real world data that remains securely within the health system, but also address workflow challenges,” said Lisa Sniderman King, Senior Director, Scientific Affairs and Diagnostics, US Medical at Sanofi.

    The technology integrates with existing EHR systems, scheduling tools, and communication platforms, delivering insights directly into clinical workflows. Population health dashboards further enable health system leaders to spot care gaps and ensure guideline adherence.

    While the initial focus is on AATD, both companies envision broader applications for respiratory and rare diseases such as severe asthma and COPD. Dr. Vibhor Gupta, CEO and Founder of Pangaea Data, commented, “We are excited to work with Sanofi beginning with AATD while advancing a broader vision for scalable, guideline-configured AI that can help scale earlier detection, screening and management across chronic and rare hard-to-diagnose conditions.”